B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses.

Verhoeven, Dorit; Grinwis, Lucas; Marsman, Casper; Jansen, Machiel H; Van Leeuwen, Ester Mm; Kuijpers, Taco W

Verhoeven, Dorit; Grinwis, Lucas; Marsman, Casper; Jansen, Machiel H; Van Leeuwen, Ester Mm; Kuijpers, Taco W.

Afiliação

Verhoeven D; Amsterdam UMC, University of Amsterdam, Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam, The Netherlands d.verhoeven1@amsterdamumc.nl.
Grinwis L; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
Marsman C; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
Jansen MH; Sanquin Research and Landsteiner Laboratory, University of Amsterdam, Department of Immunopathology, Amsterdam, The Netherlands.
Kuijpers TW; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.

Life Sci Alliance ; 6(9)2023 09.

Article em En | MEDLINE | ID: mdl-37419630

Assuntos

Mieloma Múltiplo; Humanos; Mieloma Múltiplo/tratamento farmacológico; Mieloma Múltiplo/genética; Mieloma Múltiplo/patologia; ADP-Ribosil Ciclase 1/genética; ADP-Ribosil Ciclase 1/metabolismo; NF-kappa B; Diferenciação Celular

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Revista: Life Sci Alliance Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google